These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 520761)
1. Correlation between lymphocyte responsiveness to mitogens and results of chemo-immunotherapy in patients with advanced cancer. Toge T; Yamada Y; Ikeda H; Niimoto M; Hattori T Gan; 1979 Oct; 70(5):699-703. PubMed ID: 520761 [TBL] [Abstract][Full Text] [Related]
2. Effect of immunochemotherapy on lymphocyte response of patients with gastrointestinal cancer. Mashiba H; Yoshinaga H; Matsunaga K; Gojobori M; Furusawa M J Surg Oncol; 1979; 12(3):275-9. PubMed ID: 502567 [TBL] [Abstract][Full Text] [Related]
3. Clinical studies on cell-mediated immunity in patients with malignant disease. I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro. Uchida A; Hoshino T Cancer; 1980 Feb; 45(3):476-83. PubMed ID: 6965464 [TBL] [Abstract][Full Text] [Related]
4. Immunological basis and immunotherapy of nasopharyngeal carcinoma. Tsukuda M; Sawaki S Auris Nasus Larynx; 1985; 12 Suppl 2():S161-5. PubMed ID: 3939185 [TBL] [Abstract][Full Text] [Related]
5. Clinical value of immunochemotherapy with OK-432 or PS-K for stomach cancer patients. Fujimoto S; Takahashi M; Minami T; Ishigami H; Miyazaki M; Itoh K Jpn J Surg; 1979 Sep; 9(3):190-6. PubMed ID: 470251 [TBL] [Abstract][Full Text] [Related]
6. Two phenotypically distinct suppressor T cell subpopulations inhibit the induction of B cell differentiation by phytohemagglutinin. Clement LT; Dagg MK; Lehmeyer JE; Kiyotaki M J Immunol; 1983 Sep; 131(3):1214-7. PubMed ID: 6224852 [TBL] [Abstract][Full Text] [Related]
7. [Adjuvant immunochemotherapy with long-term OK-432 administration in colorectal cancer]. Kikkawa N; Sasai H; Kawahara T Gan To Kagaku Ryoho; 1984 Oct; 11(10):2163-9. PubMed ID: 6486832 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant immunotherapy with a S. pyogenes preparation (OK432) in urogenital cancer patients. Nakagami Y; Chin H; Tannowa K; Matsumoto K; Kawai H Invest Urol; 1980 Mar; 17(5):386-9. PubMed ID: 6965669 [TBL] [Abstract][Full Text] [Related]
9. [Transformation of separated lymphocytes from the blood of patients with infectious mononucleosis in the presence of phytohemagglutinins (PHA), pokeweed mitogen (PWM) and human growth hormone (STHh, HGH)]. Softić N; Jeren T; Pfeifer S; Flegar Z Acta Med Iugosl; 1978; 32(5):441-62. PubMed ID: 742407 [No Abstract] [Full Text] [Related]
10. Evaluation of lymphocyte populations and their mitogenic activity in relation to serum copper and immunoglobulin levels in rheumatoid arthritis. Attia WM; Clark HW; Brown TM Ann Allergy; 1981 Aug; 47(2):99-103. PubMed ID: 7258747 [TBL] [Abstract][Full Text] [Related]
11. Lymphocyte function in patients with recurrent aphthous ulcers. Sun A; Wu YC; Kwan HW Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):204-9. PubMed ID: 3428014 [TBL] [Abstract][Full Text] [Related]
12. [Lymphocyte responsiveness in the peripheral blood to nonspecific mitogens and the TH and TS lymphocyte subpopulation in progressive polyarthritis]. Strejcek J; Jíra M; Horký J; Antosová E Cas Lek Cesk; 1985 Nov; 124(44):1361-5. PubMed ID: 3877570 [No Abstract] [Full Text] [Related]
13. Reactivity of ovine lymphocytes to phytohaemagglutinin and pokeweed mitogen during pregnancy and in the immediate post-parturient period. Burrells C; Wells PW; Sutherland AD Clin Exp Immunol; 1978 Sep; 33(3):410-5. PubMed ID: 737895 [TBL] [Abstract][Full Text] [Related]
14. The effect of maintenance dialysis on lymphocyte function. I. Haemodialysis. Holdsworth SR; Fitzgerald MG; Hosking CS; Atkins RC Clin Exp Immunol; 1978 Jul; 33(1):95-101. PubMed ID: 709914 [TBL] [Abstract][Full Text] [Related]
15. Lymphocyte subpopulations and reactivity to mitogens in patients with scleroderma. Baron M; Keystone EC; Gladman DD; Lee P; Poplonski L Clin Exp Immunol; 1981 Oct; 46(1):70-6. PubMed ID: 6978216 [TBL] [Abstract][Full Text] [Related]
16. [Effect of immunotherapy using the non-specific immunopotentiator OK-432 in malignant ovarian tumors--selecting appropriate cases for immunotherapy]. Nishida Y; Sakakibara K; Kano T; Ohta M; Tomoda Y Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jul; 38(7):1017-25. PubMed ID: 3746020 [TBL] [Abstract][Full Text] [Related]
17. [Response of peripheral blood lymphocytes to antigenically nonspecific mitogens in systemic erythematosus]. Strejcek J; Jíra M Cas Lek Cesk; 1989 Jun; 128(25):781-3. PubMed ID: 2766336 [TBL] [Abstract][Full Text] [Related]
18. [Experimental and clinical study of adoptive immunotherapy combined with preadministration of OK-432: a method to augment the therapeutic effect]. Kan N; Okino T; Nakanishi M; Sato K; Mise K; Teramura Y; Yamasaki S; Hori T; Ohgaki K; Tobe T Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1455-61. PubMed ID: 2786379 [TBL] [Abstract][Full Text] [Related]
19. In vitro modulation of interleukin-2-mediated human peripheral mononuclear cell proliferation and antitumor cytotoxicity by 5-fluorouracil. Brazowski E; Eytan K; Eisenthal A Anticancer Res; 2007; 27(6B):4135-41. PubMed ID: 18225584 [TBL] [Abstract][Full Text] [Related]
20. Blastogenic responses of human lymphocytes to a streptococcal preparation OK-432 and its fractions. Tanaka T; Kaneko Y; Haba F; Katsuta S; Tsutsui K; Tamaki S; Chen DR; Suzuki S; Ueda R; Yamamoto A J Clin Lab Immunol; 1989 Feb; 28(2):91-6. PubMed ID: 2787407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]